Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.

[1]  G. Kalemkerian.  Biology of lung cancer. , 1994, Current opinion in oncology.

[2]  D. Carney.  The biology of lung cancer. , 1995, Current opinion in oncology.

[3]  H. Demura,et al.  [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. , 1989, Gan no rinsho. Japan journal of cancer clinics.

[4]  K. Shimokata,et al.  Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy. , 1989, Chest.

[5]  H. Hansen,et al.  Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. , 1989, European journal of cancer & clinical oncology.

[6]  P. Hasleton,et al.  The value of tumour markers in lung cancer. , 1988, British Journal of Cancer.

[7]  M. Klockars,et al.  Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report. , 1988, The European respiratory journal.

[8]  P. Cremaschi,et al.  Detection of malignant pleural effusions by tumor marker evaluation. , 1988, European journal of cancer & clinical oncology.

[9]  W. Wilmanns,et al.  Tumour associated antigens in diagnosis of serous effusions. , 1988, Journal of clinical pathology.

[10]  Y. Moriwaki,et al.  Tumor markers in pleural effusion diagnosis , 1988, Cancer.

[11]  D. Carney,et al.  Biochemical markers of lung cancer , 1988 .

[12]  J. Silverman,et al.  The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions , 1987, Diagnostic cytopathology.

[13]  E. Cibas,et al.  The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen. , 1987, Human pathology.

[14]  W. Lo,et al.  [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions]. , 1986, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[15]  P. Bayer,et al.  [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. , 1986, Wiener klinische Wochenschrift.

[16]  W. Wilmanns,et al.  Tumormarker in der Diagnostik von Aszites- und Pleurapunktaten , 1986 .

[17]  K. Shimokata,et al.  Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions. , 1986, Japanese journal of clinical oncology.

[18]  D. Whitaker,et al.  Pleural Fluid Cea Levels in the Diagnosis of Malignant Mesothelioma , 1986, Pathology.

[19]  D. Longo,et al.  Tumor markers: value and limitations in the management of cancer patients. , 1985, Cancer treatment reviews.

[20]  L. Bonomo,et al.  Diagnostic Value of Carcinoembryonic Antigen (CEA) Assay in Pleural Effusions , 1984, Tumori.

[21]  M. Fukuoka,et al.  Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients. , 1984, Japanese journal of clinical oncology.

[22]  J. Minna,et al.  SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER , 1982, The Lancet.